Pharmaceutical

Novo Nordisk engages Thermo Fisher to produce weight-loss drug

Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the weight-loss drug, Wegovy (semaglutide), Reuters reported.

Aug 26, 2023 - 20:00
Novo Nordisk engages Thermo Fisher to produce weight-loss drug
Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the weight-loss drug, Wegovy (semaglutide), Reuters reported.
Read the original article

Tags:

Previous Article

Pfizer’s first-ever bispecific antibody Elrexfio holds promise in multiple myeloma

Next Article

FDA grants clearance to Gilead Sciences’ sNDA for Veklury

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Bankrupt Pear’s addiction treatments acquired by virtual care company

STAT+: Bankrupt Pear’s addiction treatments acquired by...

Dec 13, 2023

Panbela Therapeutics and Johns Hopkins to expand ivospemin development

Panbela Therapeutics and Johns Hopkins to expand ivospe...

Apr 4, 2023

Scottish company secures £4.2m to advance 3D-printed micro-tumour tech

Scottish company secures £4.2m to advance 3D-printed mi...

Feb 2, 2024